Filana Therapeutics, Inc. (NASDAQ: FLNA, “Filana Therapeutics”, the “Company”), a biotechnology company currently focused on ...
Apertura Gene Therapy, a biotechnology company developing next-generation AAV capsids for delivering genetic medicines, and ...
Adjunctive cannabidiol improved multiple TSC-associated neuropsychiatric symptoms, including irritability, in a phase 3b/4 study described by investigators as the first to assess these outcomes.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results